(CNN) — The first participants have been vaccinated in a Phase 1 clinical trial of an experimental HIV vaccine that utilizes Moderna’s mRNA technology, the company announced last week.
The trial, titled IAVI G002, is being conducted in partnership with IAVI, a nonprofit scientific research organization. It is testing a vaccine that delivers HIV-specific antigens to the body with the goal of inducing an immune response. These antigens were initially developed by researchers at IAVI and Scripps Research, led by Dr. William Schief.
In a “proof-of-concept” trial last year, the research team found the HIV antigens produced the desired immune response in 97% of participants. The current trial builds on the previous one by testing the primary version of the vaccine and also a booster version, and by employing Moderna’s mRNA technology, which was previously used to create a successful Covid-19 vaccine.
“We are tremendously excited to be advancing this new direction in HIV vaccine design with Moderna’s mRNA platform. The search for an HIV vaccine has been long and challenging, and having new tools in terms of immunogens and platforms could be the key to making rapid progress toward an urgently needed, effective HIV vaccine,” Mark Feinberg, IAVI’s president and CEO, said in a news release from Moderna.
The new trial, funded in part by the Bill & Melinda Gates Foundation, will follow 56 HIV-negative adult participants, with the goal of studying both the safety and efficacy of the vaccine. Forty-eight of the volunteers will receive at least one dose of the primary vaccine, 32 of which will also receive the booster. The remaining eight will receive the booster vaccine alone.
The trial includes participants from four locations: George Washington University School of Medicine, Hope Clinic of Emory Vaccine Center, Fred Hutchinson Cancer Research Center, and the University of Texas Health Science Center at San Antonio.
The post First patients vaccinated in clinical trial of HIV experimental vaccine appeared first on East Idaho News.
Source: eastidahonews.com
First patients vaccinated in clinical trial of HIV experimental vaccine
More from HealthMore posts in Health »
- Supreme Court appears skeptical that state abortion bans conflict with federal health care law
- U.S. Supreme Court hears arguments on Idaho abortion law. How did we get here?
- 3 questions you need to ask yourself about your diet
- 8.2 million packets of Tide, Gain, Ace, and Ariel detergent pods recalled over faulty packaging
- Air Idaho Rescue now carrying whole blood on every flight
More from NationalMore posts in National »
- Supreme Court appears skeptical that state abortion bans conflict with federal health care law
- Biden says the US is rushing weaponry to Ukraine as he signs a $95 billion war aid measure into law
- You have to see this! Country superstar falls on stage after slipping on fan’s phone
- Supreme Court will decide whether Trump is immune from federal prosecution. Here’s what’s next
- Trump tried to ‘corrupt’ the 2016 election, prosecutor alleges as hush money trial gets underway
Be First to Comment